ZIKAlliance

The project main objective if to investigate clinical, fundamental, environmental and social aspects of ZIKV infection.

Abstract of the project:

ZIKAlliance is a multidisciplinary project with a global “One Health” approach, built: on a multi-centric network of clinical cohorts in the Caribbean,
Central & South America; research sites in countries where the virus has been or is currently circulating (Africa, Asia, Polynesia) or at risk for
emergence (Reunion Island); a strong network of European and Brazilian clinical & basic research institutions; and multiple interfaces with other
scientific and public health programmes. ZIKAlliance will address three key objectives relating to (I) impact of Zika virus (ZIKV) infection during
pregnancy and short & medium term effects on newborns, (ii) associated natural history of ZIKV infection in humans and their environment in the
context of other circulating arboviruses and (iii) building the overall capacity for preparedness research for future epidemic threats in Latin America & the Caribbean.

The project will take advantage of large standardised clinical cohorts of pregnant women and febrile patients in regions of Latin America and the Caribbean were the virus is circulating, expanding a pre-existing network established by the IDAMS EU project. I will also benefit of a very strong expertise in basic and environmental sciences, with access to both field work and sophisticated technological infrastructures to characterise virus replication and physiopathology mechanisms. To meet its 3 key objectives, the scientific project has been organised in 9 work packages, with WP2/3 dedicated to clinical research (cohorts, clinical biology, epidemiology & modelling), WP3/4 to basic research (virology & antivirals, pathophysiology & animal models), WP5/6 to environmental research (animal reservoirs, vectors & vector control) , WP7/8 to social sciences & communication, and WP9 to management. The broad consortium set-up allow gathering the necessary expertise for an actual interdisciplinary approach, and operating in a range of countries with contrasting ZIKV epidemiological status.